Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/8JM stock hub

FRA/8JM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/8JMis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
876.4M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/8JMFRA/8JM
Loading chart…
In the news

Latest news · FRA/8JM

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15
P25 n/aP50 n/aP75 n/a
Trailing P/E15.3
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC27.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/8JM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
160
Groups with data
9
Currency
EUR
Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
France
Country code
DE
Employees
2,497
Employees Change
-4%
Employees Change Percent
-0.16
Enterprise value
EUR 712.7M
Exchange
Frankfurt Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 876.4M
Price
EUR 73.6
Price currency
EUR
Rev Per Employee
210,532.64x
Sic
2834
Symbol
fra/8JM
Website
https://www.vetoquinol.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
6.54%
EV Earnings
12.44x
EV/EBIT
9.1x
EV/EBITDA
6.29x
EV/Sales
1.36x
Forward P/E
15.04x
P/E ratio
15.3x
P/S ratio
1.67x
PE Ratio10 Y
22.07x
PE Ratio3 Y
16.09x
PE Ratio5 Y
18.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
14.89%
EBITDA Margin
21.57%
Gross margin
56.31%
Gross Profit
EUR 296M
Gross Profit Growth
-3.97%
Gross Profit Growth Q
-7.27%
Gross Profit Growth3 Y
0.98%
Gross Profit Growth5 Y
0.28%
Net Income
EUR 57.3M
Net Income Growth
-2.36%
Net Income Growth Q
-7.62%
Net Income Growth3 Y
6.72%
Net Income Growth5 Y
-0.52%
Pretax Margin
15.26%
Profit Margin
10.9%
Profit Per Employee
EUR 22,948
ROIC
27.71
Roic5y
17.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr1y
1.51%
Cagr3y
-6.48%
Cagr5y
-6.09%
Div CAGR10
8.6%
Div CAGR3
3.62%
Div CAGR5
12.22%
FCF Growth
1.15%
FCF Growth Q
37.91%
FCF Growth3 Y
-0.06%
FCF Growth5 Y
-4.09%
OCF Growth
-15.99%
OCF Growth Q
2.04%
OCF Growth10 Y
-2.43%
OCF Growth3 Y
-5.66%
OCF Growth5 Y
-7.41%
Revenue Growth
-2.5x
Revenue Growth Q
-2.44x
Revenue Growth3 Y
-0.74x
Revenue Growth5 Y
0.02x

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Dividend Growth
4.71%
Dividend Growth Years
2%
Dividend per share
EUR 0.89
Dividend Years
5
Dividend Yield
1.21%
Ex Div Date
2025-06-04
Last Dividend
EUR 0.89
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
1.51%
200-day SMA
77.78
3Y total return
-18.21%
50-day SMA
78.49
50-day SMA vs 200-day SMA
50over200
5Y total return
-26.96%
All Time High
151.6
All Time High Change
-51.45%
All Time High Date
2021-11-08
All Time Low
63.1
All Time Low Change
16.64%
All Time Low Date
2025-01-24
ATR
1.95
Ch YTD
-11
High
73.6
High52
89.7
High52 Date
2026-02-16
High52ch
-17.95%
Low
73.6
Low52
68.7
Low52 Date
2025-06-18
Low52ch
7.13%
Ma50ch
-6.23%
Price vs 200-day SMA
-5.37%
RSI
41.71
RSI Monthly
42.69
RSI Weekly
40.88
Sharpe ratio
0.13x
Sortino ratio
0.4
Total Return
1.21%
Tr YTD
-11
Tr1m
-4.17%
Tr1w
-3.54%
Tr3m
-12.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 78.3M
Operating Income Growth
-2.16
Operating Income Growth Q
-2.67
Operating Income Growth3 Y
5.39
Operating Income Growth5 Y
-1.1
Operating margin
14.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

3
MetricValue
Float
3,827,225%
Shares Insiders
4.02%
Shares Institutions
8.41%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

43
MetricValue
Average Volume
19.6x
Ch1m
-4.17
Ch1w
-3.54
Ch1y
0.27
Ch3m
-12.38
Ch3y
-20.6
Ch5y
-29.9
Ch6m
2.94
Change
-1.21%
Change From Open
0
Close
74.5
Days Gap
-1.21
Depreciation Amortization
35,100,000
Earnings Date
2026-09-11
EBIT
EUR 78.3M
EBITDA
EUR 113.4M
F Score
3
Financing CF
-25,100,000
Fiscal Year End
December
Founded
1,933
Income Tax
EUR 22.9M
Investing CF
-20,600,000
Is Primary Listing
0
Last Earnings Date
2026-03-27
Last Report Date
2025-12-31
Lynch Fair Value
EUR 24.06
Lynch Upside
-67.31
Ma150
78.65
Ma150ch
-6.42%
Ma20
78.24
Ma20ch
-5.93%
Net CF
18,500,000
Next Earnings Date
2026-09-11
Open
73.6
P OCF Ratio
12.16
Payment Date
2025-06-06
Price Date
2026-05-08
Price EBITDA
EUR 7.73
Relative Volume
6.89x
Revenue
525,700,000x
Tax By Revenue
4.36x
Tax Rate
28.55%
Tr6m
2.94%
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/8JM dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.2%
$0.89 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+12.2%
2 consecutive years of growth
Total shareholder yield
+1.2%
Next ex-dividend date: 2025-06-04
Performance

FRA/8JM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+1.5%
S&P 500 1Y: n/a
3Y total return
-18.2%
S&P 500 3Y: n/a
5Y total return
-27.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/8JM?

Insider, institutional, and short-interest positioning.

Institutional ownership
+8.4%
Share of float held by funds and institutions
Insider ownership
+4.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

FRA/8JM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
41.7
Neutral momentum band
Price vs 200-day MA
-5.4%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.13
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/8JM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/8JM stock rating?

fra/8JM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/8JM analysis?

The full report lives at /stocks/fra/8JM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/8JM?

The latest report frames fra/8JM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/8JM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.